154 related articles for article (PubMed ID: 26689153)
1. Good response to long-term therapy with growth hormone in a patient with 9p trisomy syndrome: A case report and review of the literature.
Canton AP; Nishi MY; Furuya TK; Roela RA; Jorge AA
Am J Med Genet A; 2016 Apr; 170A(4):1046-9. PubMed ID: 26689153
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics and Long-Term Recombinant Human Growth Hormone Treatment of 18q- Syndrome: A Case Report and Literature Review.
Liu S; Chen M; Yang H; Chen S; Wang L; Duan L; Zhu H; Pan H
Front Endocrinol (Lausanne); 2021; 12():776835. PubMed ID: 34956087
[TBL] [Abstract][Full Text] [Related]
3. The phenotype and rhGH treatment response of ring Chromosome 15 Syndrome: Case report and literature review.
Chen M; Ke X; Liang H; Gong F; Yang H; Wang L; Duan L; Pan H; Cao D; Zhu H
Mol Genet Genomic Med; 2021 Dec; 9(12):e1842. PubMed ID: 34747577
[TBL] [Abstract][Full Text] [Related]
4. Array-CGH study of partial trisomy 9p without mental retardation.
Bouhjar IB; Hannachi H; Zerelli SM; Labalme A; Gmidène A; Soyah N; Missaoui S; Sanlaville D; Elghezal H; Saad A
Am J Med Genet A; 2011 Jul; 155A(7):1735-9. PubMed ID: 21626676
[TBL] [Abstract][Full Text] [Related]
5. Long-term response to growth hormone therapy in a patient with short stature caused by a novel heterozygous mutation in NPR2.
Vasques GA; Hisado-Oliva A; Funari MF; Lerario AM; Quedas EP; Solberg P; Heath KE; Jorge AA
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):111-116. PubMed ID: 27941173
[TBL] [Abstract][Full Text] [Related]
6. Long-term auxological and endocrinological evaluation of patients with 9p trisomy: a focus on the growth hormone-insulin-like growth factor-I axis.
Stagi S; Lapi E; Seminara S; Guarducci S; Pantaleo M; Giglio S; Chiarelli F; de Martino M
BMC Endocr Disord; 2014 Jan; 14():3. PubMed ID: 24397778
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of the influencing factors of recombinant human growth hormone effect in the children with Turner syndrome].
Li J; Wu W; Liang Y; Luo XP
Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):866-870. PubMed ID: 30392213
[No Abstract] [Full Text] [Related]
8. Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.
Wassenaar MJ; Dekkers OM; Pereira AM; Wit JM; Smit JW; Biermasz NR; Romijn JA
J Clin Endocrinol Metab; 2009 Oct; 94(10):3721-30. PubMed ID: 19584188
[TBL] [Abstract][Full Text] [Related]
9. Response to growth hormone therapy in ring chromosome 15: Review and evidence from a new case on possible beneficial effect in neurodevelopment.
Wannes S; El Ahmer I; Rjiba K; Jemmali N; Abdallah HH; Haj RB; Achour A; Bouzidi H; Saad A; Mougou S; Mahjoub B
Growth Horm IGF Res; 2023 Aug; 71():101550. PubMed ID: 37531800
[TBL] [Abstract][Full Text] [Related]
10. [Misdiagnosis of mosaic tetrasomy 9p in a fetus by single nucleotide polymorphism-based array].
Wu J; Xie Y; Chen B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):830-3. PubMed ID: 26663059
[TBL] [Abstract][Full Text] [Related]
11. Pure 9p trisomy derived from a terminal balanced unreciprocal translocation.
Brambila-Tapia AJ; Neira VA; Vásquez-Velásquez AI; Jimenez-Arredondo RE; Chávez-González EL; Picos-Cárdenas VJ; Fletes-Rayas AL; Figuera LE
Genet Couns; 2014; 25(3):289-97. PubMed ID: 25365851
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH.
Chen M; Miao H; Liang H; Ke X; Yang H; Gong F; Wang L; Duan L; Chen S; Pan H; Zhu H
Front Endocrinol (Lausanne); 2022; 13():820001. PubMed ID: 35250876
[TBL] [Abstract][Full Text] [Related]
13. [Pure trisomy 9p 47,XX,+ del(9) (q11). Discovery of one cell 46,XX, del(9) (q11) in the father].
Turleau C; De Grouchy J; Roubin M; Chavin-Colin F; Cachin O
Ann Genet; 1975 Jun; 18(2):125-9. PubMed ID: 1081365
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a Complex Chromosomal Rearrangement Involving a de novo Duplication of 9p and 9q and a Deletion of 9q.
Martín-De Saro MD; Valdés-Miranda JM; Plaza-Benhumea L; Pérez-Cabrera A; Gonzalez-Huerta LM; Guevara-Yañez R; Cuevas-Covarrubias SA
Cytogenet Genome Res; 2015; 147(2-3):124-9. PubMed ID: 26900692
[TBL] [Abstract][Full Text] [Related]
15. De-novo 'pure' partial trisomy (6)(p22.3→pter): a case report and review of the literature.
Sivasankaran A; Murthy K; Oruganti VP; Deenadayalu A; R Samuel C; Kandukuri LR
Clin Dysmorphol; 2017 Jan; 26(1):26-32. PubMed ID: 27759572
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular delineation of Tetrasomy 9p syndrome: report of 12 new cases and literature review.
El Khattabi L; Jaillard S; Andrieux J; Pasquier L; Perrin L; Capri Y; Benmansour A; Toutain A; Marcorelles P; Vincent-Delorme C; Journel H; Henry C; De Barace C; Devisme L; Dubourg C; Demurger F; Lucas J; Belaud-Rotureau MA; Amiel J; Malan V; De Blois MC; De Pontual L; Lebbar A; Le Dû N; Germain DP; Pinard JM; Pipiras E; Tabet AC; Aboura A; Verloes A
Am J Med Genet A; 2015 Jun; 167(6):1252-61. PubMed ID: 25847481
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of a new acid-labile subunit (IGFALS) heterozygous mutation: anthropometric and biochemical characterization and response to growth hormone administration.
Grandone A; Miraglia del Giudice E; Cirillo G; Abbondanza C; Cioffi M; Romano T; Micillo F; Marzuillo P; Perrone L
Horm Res Paediatr; 2014; 81(1):67-72. PubMed ID: 24356109
[TBL] [Abstract][Full Text] [Related]
18. Abnormal chromosome 9 in a neonate program. Report of three cases.
Nakamura Y; Sato E; Sakai K; Sakuma S; Hashimoto T; Sindou S
Arch Pathol Lab Med; 1990 Feb; 114(2):185-7. PubMed ID: 2302035
[TBL] [Abstract][Full Text] [Related]
19. [Improved identification for 5p deletion syndrome and partial trisomy 11q presented in a fetus by SNP array].
Shi S; Pan G; Yang Y; Yan R; Li W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Apr; 33(2):195-9. PubMed ID: 27060314
[TBL] [Abstract][Full Text] [Related]
20. Trisomy 4 mosaicism: Delineation of the phenotype.
Bouman A; van der Kevie-Kersemaekers AM; Huijsdens-van Amsterdam K; Dahhan N; Knegt L; Vansenne F; Cobben JM
Am J Med Genet A; 2016 Apr; 170A(4):1040-5. PubMed ID: 26789019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
